Clinical and Surgical Insights into Zuska Disease: A Retrospective Analysis
Authors:
- Letizia CunioloLCLetizia Cuniolo
- Raquel DiazRDRaquel Diaz
- Francesca PittoFPFrancesca Pitto
- Federica MurelliFMFederica Murelli
- Chiara CornacchiaCCChiara Cornacchia
- Francesca DepaoliFDFrancesca Depaoli
- Marco GipponiMGMarco Gipponi
- Cecilia MargarinoCMCecilia Margarino
- Chiara BoccardoCBChiara Boccardo
- Simonetta FranchelliSFSimonetta Franchelli
- Marianna PesceMPMarianna Pesce
- Franco De CianFCFranco De Cian
Open Access
- 25 April 2025
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (5) , 170
Abstract
Background/Objectives: Zuska disease is a rare inflammatory condition of the mammary gland, characterized by recurrent non-puerperal abscesses in the periareolar region, often complicated by fistula formation. It predominantly affects women who smoke, particularly perimenopausal women. This study aims to investigate the clinical features, treatment outcomes, and recurrence rates of Zuska disease in a cohort of patients. Methods: We conducted a retrospective analysis of 19 patients diagnosed with Zuska disease and treated at the Breast Surgery Clinic of San Martino Policlinic Hospital between January 2021 and June 2024. Data were collected on demographics, clinical presentation, imaging findings, surgical interventions, intraoperative cultures, and postoperative outcomes. The types of surgeries performed, antibiotic therapy regimens, and histological findings were recorded. Results: The mean age of the patients was 43.8 years. The most common presentation was a painful breast mass without fistula formation (12 patients), signs of a past abscess with negative preoperative ultrasound findings (five patients), and abscesses with fistulas (two patients). Intraoperative cultures revealed a range of bacterial species. Recurrence occurred in five patients (26%), and reoperation was required in three cases. All patients were free of symptoms at follow-up, with an average recurrence time of 13.6 months. Conclusions: Zuska disease presents significant treatment challenges due to its recurrent nature. While surgical interventions, such as abscess drainage and ductal excision, are effective, recurrence remains common, particularly in patients with risk factors like smoking. A personalized therapeutic approach, tailored to each patient’s clinical profile, is essential to improving long-term outcomes. Early diagnosis, timely surgical management, and lifestyle modifications play a crucial role in reducing recurrence. Future studies should focus on optimizing treatment protocols and developing individualized strategies for managing comorbidities.Keywords
This publication has 32 references indexed in Scilit:
- Management of Mastitis, Abscess, and FistulaSurgical Clinics of North America, 2022
- Microbiología de los abscesos mamariosEnfermedades Infecciosas y Microbiología Clínica, 2022
- Image-Guided Breast Interventions: Biopsy and BeyondIndian Journal of Radiology and Imaging, 2021
- Nonpuerperal breast abscess due to Prevotella biviaClinical Case Reports, 2020
- Infections in the Breast—Common Imaging Presentations and MimicsSeminars in Roentgenology, 2017
- Dynamics of Breast Milk HIV-1 RNA With Unilateral Mastitis or AbscessJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- Follicular occlusion due to hyperkeratosis: A new hypothesis on the pathogenesis of mammillary fistulaMedical Hypotheses, 2010
- Risk Factors for Development and Recurrence of Primary Breast AbscessesJournal of the American College of Surgeons, 2010
- Treatment of Mammary Duct Fistula by Fistulectomy and SaucerizationWorld Journal of Surgery, 2005
- Fistulas of lactiferous ductsThe American Journal of Surgery, 1951